Sally K. Mak
- Neurology top 2%
- Molecular Biology
- Cellular and Molecular Neuroscience top 5%
- Physiology top 10%
- Cell Biology top 10%
- Co-authors
- Donato A. Di MonteAlison L. McCormackDietmar KültzAmy Manning-BogAna María CuervoJ. William LangstonBirgitt SchüleMatthew J. Farrer
- Topics
- Parkinson's Disease Mechanisms and Treatments (9 papers)Alzheimer's disease research and treatments (5 papers)Genetic Neurodegenerative Diseases (3 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Sally K. Mak
18 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Neurology 656
- Molecular Biology 510
- Cellular and Molecular Neuroscience 377
- Physiology 314
- Cell Biology 187
Countries citing papers authored by Sally K. Mak
This map shows the geographic impact of Sally K. Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally K. Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally K. Mak more than expected).
Fields of papers citing papers by Sally K. Mak
This network shows the impact of papers produced by Sally K. Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally K. Mak. The network helps show where Sally K. Mak may publish in the future.
Co-authorship network of co-authors of Sally K. Mak
This figure shows the co-authorship network connecting the top 25 collaborators of Sally K. Mak. A scholar is included among the top collaborators of Sally K. Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally K. Mak. Sally K. Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 69 | |
| 3 | 216 | |
| 4 | 1 | |
| 5 | 92 | |
| 6 | 59 | |
| 7 | 51 | |
| 8 | 25 | |
| 9 | 125 | |
| 10 | 278 | |
| 11 | 37 | |
| 12 | 64 | |
| 13 | 8 | |
| 14 | 11 | |
| 15 | 51 | |
| 16 | 41 | |
| 17 | 63 | |
| 18 | 76 |
About Sally K. Mak
Sally K. Mak is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (9 papers), Alzheimer's disease research and treatments (5 papers) and Genetic Neurodegenerative Diseases (3 papers). The work is most often cited by research in Neurology (656 citations), Cellular and Molecular Neuroscience (377 citations) and Neurology (125 citations). Sally K. Mak has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Donato A. Di Monte, Alison L. McCormack, Dietmar Kültz, Amy Manning-Bog, Ana María Cuervo, J. William Langston, Birgitt Schüle, Matthew J. Farrer, David Bumcrot and Jaimie M. Henderson. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Analytica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.